Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Falk

Showing results (251-260 of 537) with videos related to

Pageof 54
Sort By:
The American Journal of Cardiology|October 1, 1995
Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survivalS Dubrey, R W Simms, M Skinner, et al.
Journal of Periodontology|June 1, 1997
Guided tissue regeneration therapy of 203 consecutively treated intrabony defects using a bioabsorbable matrix barrier. Clinical and radiographic findingsH Falk, L Laurell, N Ravald, et al.
Lancet (London, England)|November 24, 1979
Hepatic angiosarcoma associated with androgenic-anabolic steroidsH Falk, L B Thomas, H Popper, et al.
Medical Engineering & Physics|May 21, 2010
Vocalization removal for improved automatic segmentation of dual-axis swallowing accelerometry signalsErvin Sejdić, Tiago H Falk, Catriona M Steele, et al.
Virology|July 1, 1991
cis Acting RNA sequences control the gag-pol translation readthrough in murine leukemia virusA Honigman, D Wolf, S Yaish, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1977
Tobramycin and clindamycin in the treatment of febrile leukaemic patientsR H Falk, A P Gillett, R Wise, et al.
Swedish Dental Journal|July 20, 2000
Treatment of class II furcation defects using resorbable and non-resorbable GTR barriersS Karapataki, H Falk, A Hugoso, et al.
Clinical Oral Implants Research|September 1, 1994
The use of a new bioresorbable barrier for guided bone regeneration in connection with implant installation. Case reportsD Lundgren, L Sennerby, H Falk, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicityN Mador, H Falk, M Bergel, et al.
Virology|April 1, 1995
Translation efficiency of the human T-cell leukemia virus (HTLV-2) gag gene modulates the frequency of ribosomal frameshiftingA Honigman, H Falk, N Mador, et al.
Pageof 54

Showing results (251-260 of 537) with videos related to

Sort By:
Pageof 54
The American Journal of Cardiology|October 1, 1995
Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survivalS Dubrey, R W Simms, M Skinner, et al.
Journal of Periodontology|June 1, 1997
Guided tissue regeneration therapy of 203 consecutively treated intrabony defects using a bioabsorbable matrix barrier. Clinical and radiographic findingsH Falk, L Laurell, N Ravald, et al.
Lancet (London, England)|November 24, 1979
Hepatic angiosarcoma associated with androgenic-anabolic steroidsH Falk, L B Thomas, H Popper, et al.
Medical Engineering & Physics|May 21, 2010
Vocalization removal for improved automatic segmentation of dual-axis swallowing accelerometry signalsErvin Sejdić, Tiago H Falk, Catriona M Steele, et al.
Virology|July 1, 1991
cis Acting RNA sequences control the gag-pol translation readthrough in murine leukemia virusA Honigman, D Wolf, S Yaish, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1977
Tobramycin and clindamycin in the treatment of febrile leukaemic patientsR H Falk, A P Gillett, R Wise, et al.
Swedish Dental Journal|July 20, 2000
Treatment of class II furcation defects using resorbable and non-resorbable GTR barriersS Karapataki, H Falk, A Hugoso, et al.
Clinical Oral Implants Research|September 1, 1994
The use of a new bioresorbable barrier for guided bone regeneration in connection with implant installation. Case reportsD Lundgren, L Sennerby, H Falk, et al.
Cancer Immunology, Immunotherapy : CII|July 1, 1997
Variant mouse lymphoma cells with modified response to interferon demonstrate enhanced immunogenicityN Mador, H Falk, M Bergel, et al.
Virology|April 1, 1995
Translation efficiency of the human T-cell leukemia virus (HTLV-2) gag gene modulates the frequency of ribosomal frameshiftingA Honigman, H Falk, N Mador, et al.
Pageof 54